Volume5, Issue0 (2019) | undefined

Hepatoma Research

Search Log In

Editor-in-Chief: Guang-Wen Cao

Indexing: ESCI, CAS, Scopus, Wanfang Data, CNKI, Dimensions, Embase, ASCI,

Journal Rank: CiteScore 3.5 - Impact Factor 1.2, Q3 (Gastroenterology & Hepatology)

Median time to first editorial decision: 10 days

Hot Keywords

Hepatocellular carcinoma HCC Liver Cancer Liver tumors Hepatoblastoma Cholangiocarcinoma Nonalcoholic fatty liver disease Nonalcoholic steatohepatitis Hepatitis B; Hepatitis C Immunotherapy Systemic treatment Liver transplantation Liver resection Surgical Management Surveillance Epidemiology Molecular mechanisms Tumor microenvironment Biomarker Stem cell

Home

About

Publish with us

Articles

Special Topics

Volumes

Features

Home Articles Special Topics Volumes Webinars Videos

Hepatoma Research

Editor-in-Chief: Guang-Wen Cao

Journal Rank: CiteScore 3.5 - Impact Factor 1.2, Q3 (Gastroenterology & Hepatology)

Median time to first editorial decision: 10 days

Home Articles Special Topics Volumes Webinars Videos

Home Volumes

Volume

Table of Contents (88 articles)

Telomerase reverse transcriptase promoter mutations in hepatocellular carcinogenesis

Zi-Xian Ma, ... Hong Tu

Hong Tu

Oncogenicity of viral hepatitis B and C in the initiation of hepatic cancer stem cells

Caecilia H. C. Sukowati

Caecilia H. C. Sukowati

, ... Claudio Tiribelli

Circulating tumor DNAs and non-coding RNAs as potential biomarkers for hepatocellular carcinoma diagnosis, prognosis and response to therapy

Paola Guerriero, ... Elisa Callegari

Elisa Callegari

Molecular diagnosis of hepatocellular carcinoma: trends in biomarkers combination to enhance early cancer detection

Tiong Sun Chia, ... John M. Luk

John M. Luk

Review of therapies for intermediate and advanced stage hepatocellular carcinoma, not suitable for curative therapies: a rapidly changing landscape

Brian I. Carr

Brian I. Carr

Hepatocellular carcinoma in non-alcoholic fatty liver disease with and without cirrhosis

Georgia Onzi, ... Jonathan Soldera

Jonathan Soldera

Novel insights of HBV RNA in hepatitis B virus pathogenesis and clinical application

Wen-Bin Ding, ... Fu Yang

Fu Yang

Efficacy and safety of stereotactic body radiation therapy combined with transarterial chemoembolization for Chinese intermediate-to advanced-stage hepatocellular carcinoma patients: a systematic review and meta-analysis

Shou-Jie Zhao, ... Yong Long

Yong Long

Molecular diagnosis and therapy of hepatocellular carcinoma: achievements and challenges

Xiao-Dong Zhang

Xiao-Dong Zhang

, ... Man Zhao

Diagnostic imaging for hepatocellular carcinoma

Adriano de Santis

Adriano de Santis

, ... Giulia Gallusi

Stereotactic ablative radiotherapy for hepatocellular carcinoma

Benjamin Spieler, ... Lorraine Portelance

Lorraine Portelance

A dimethylbromobenzene-cysteine stapled peptide dual inhibitor of the p53-MDM2/MDMX interactions

Wei Jiang, ... Wang-Xiao He

Hepatocellular carcinoma in alcoholic liver disease: mechanistic considerations and clinical facts

Rolf Teschke

Rolf Teschke

Tumor growth rates and recurrence-free survival in chronic viral hepatitis patients with hepatocellular carcinoma

Myron J. Tong

Myron J. Tong

, ... David S. Lu

CT of hepatocellular carcinoma in non-alcoholic fatty liver disease: imaging characteristics and inter-rater agreement

Ishan Garg, ... Sudhakar K. Venkatesh

Sudhakar K. Venkatesh

Controversies of hepatectomy and adjuvant therapy for hepatocellular carcinoma: moving forward

Jian-Hong Zhong, ... Bang-De Xiang

Bang-De Xiang

Updates in immunotherapy for hepatocellular carcinoma

Leonardo G. da Fonseca

Leonardo G. da Fonseca

, ... Flair José Carrilho

Ten-year survival and recurrence of hepatocellular cancer

Tomoki Sempokuya, ... Linda L. Wong

Molecular links between non-alcoholic fatty liver disease and hepatocellular carcinoma

Sana Raza, ... Rohit A. Sinha

Correction: Three primary malignancies in 17 years in a man with chronic hepatitis B

Peter D. Block, ... Hie-Won Hann

Hie-Won Hann

Hepatocellular carcinoma in HCV - liver cirrhosis before and after successful DAA treatment

Zahari Krastev, ... Teodora Komitova

An update on the histological subtypes of hepatocellular carcinoma

Regina Cheuk-Lam Lo

Regina Cheuk-Lam Lo

Liver cancer screening in China: practices and its extended questions

Jian-Guo Chen

Jian-Guo Chen

, ... Yuan-Rong Zhu

Transarterial chemoembolization combined with radiofrequency ablation in the treatment of hepatocellular carcinomas larger than 5 cm

Yi Yang, ... Wei-Lu Zhang

Contrast-enhanced ultrasound with sulphur-hexafluoride in diagnosis of early HCC in cirrhosis

Antonio Giorgio

Antonio Giorgio

, ... Valentina Giorgio

Hepatocellular carcinoma recurrence in HCV patients treated with direct-acting antivirals after curative treatment

Shinichiro Nakamura, ... Masatoshi Tanaka

Efficacy and safety of immune checkpoint therapy in hepatocellular carcinoma: meta-analysis

Weina Tang, ... Hong-Wei Zhang

Hong-Wei Zhang

Third time re-irradiation of liver metastasis with robotic radiosurgery: a case series

Debnarayan Dutta

Debnarayan Dutta

, ... Raghavendra Holla

Advances in early diagnosis of hepatocellular carcinoma

Partha Pratim Bose

Partha Pratim Bose

, ... Urmimala Chatterjee

Liver carcinogenesis: diagnostic and clinical aspects of preneoplastic nodules

Mauro Borzio

Mauro Borzio

, ... Giampiero Francica

Hepatocellular carcinoma occurred in a Hepatitis B carrier clinic cohort during a mean follow up of 10 years

Cheng-Jen Chen, ... Dar-In Tai

Dar-In Tai

Advances in surface markers of liver cancer stem cell

Jin-Liang Zhang, ... Xin-Yuan Guan

Xin-Yuan Guan

HCC incidence and recurrence after DAAs: new insights

Necati Örmeci

Necati Örmeci

Management of concomitant hepatocellular carcinoma and chronic hepatitis C: a review

Elizabeth Harrod, ... Behnam Saberi

Behnam Saberi

Three primary malignancies in 17 years in a man with chronic hepatitis B

Peter D. Block, ... Hie-Won Hann

Hie-Won Hann

No evidence for higher rates of hepatocellular carcinoma after direct-acting antiviral treatment: a meta-analysis

Stephanie M. Rutledge, ... Raymond T. Chung

Epidemiology of hepatocellular carcinoma in nonalcoholic fatty liver disease

Michihisa Moriguchi, ... Yoshito Itoh

Hepatocellular carcinoma: a new hope?

Lynn G. Feun

Lynn G. Feun

The secondary prevention of hepatitis B virus-associated hepatocellular carcinoma

Bo-Bin Hu, ... Jian-Ning Jiang

Jian-Ning Jiang

Immune checkpoint blockade therapies for HCC: current status and future implications

Ritu Shrestha, ... Aparna Jayachandran

Aparna Jayachandran

Comment on “APOBEC3B interaction with PRC2 modulates microenvironment to promote HCC progression”

Beiying Dai

Beiying Dai

The role of APOBEC3B in the development of hepatocellular carcinoma should be investigated with the consideration of hepatitis B virus evolution

Wen-Bin Liu, ... Guang-Wen Cao

Technical update on transcatheter arterial chemoembolization

Sapna Puppala

The use of cell free DNA in the diagnosis of HCC

Bubu A. Banini, ... Arun J. Sanyal

Arun J. Sanyal

Technical update on transcatheter arterial chemoembolization

Sapna Puppala

Sapna Puppala

Epidemiology of hepatocellular carcinoma in nonalcoholic fatty liver disease

Michihisa Moriguchi, ... Yoshito Itoh

Molecular links between non-alcoholic fatty liver disease and hepatocellular carcinoma

Sana Raza, ... Rohit A. Sinha

Rohit A. Sinha

An update on the histological subtypes of hepatocellular carcinoma

Regina Cheuk-Lam Lo

Regina Cheuk-Lam Lo

Hepatocellular carcinoma in alcoholic liver disease: mechanistic considerations and clinical facts

Rolf Teschke

Rolf Teschke

CT of hepatocellular carcinoma in non-alcoholic fatty liver disease: imaging characteristics and inter-rater agreement

Ishan Garg, ... Sudhakar K. Venkatesh

Sudhakar K. Venkatesh

Ten-year survival and recurrence of hepatocellular cancer

Tomoki Sempokuya, Linda L. Wong

Updates in immunotherapy for hepatocellular carcinoma

Leonardo G. da Fonseca

Leonardo G. da Fonseca

, Flair José Carrilho

Tumor growth rates and recurrence-free survival in chronic viral hepatitis patients with hepatocellular carcinoma

Myron J. Tong

Myron J. Tong

, ... David S. Lu

Hepatocellular carcinoma in HCV - liver cirrhosis before and after successful DAA treatment

Zahari Krastev, ... Teodora Komitova

The use of cell free DNA in the diagnosis of HCC

Bubu A. Banini, Arun J. Sanyal

Arun J. Sanyal

Comment on “APOBEC3B interaction with PRC2 modulates microenvironment to promote HCC progression”

Beiying Dai

Beiying Dai

Immune checkpoint blockade therapies for HCC: current status and future implications

Ritu Shrestha, ... Aparna Jayachandran

Aparna Jayachandran

No evidence for higher rates of hepatocellular carcinoma after direct-acting antiviral treatment: a meta-analysis

Stephanie M. Rutledge, ... Raymond T. Chung

The role of APOBEC3B in the development of hepatocellular carcinoma should be investigated with the consideration of hepatitis B virus evolution

Wen-Bin Liu, Guang-Wen Cao

The secondary prevention of hepatitis B virus-associated hepatocellular carcinoma

Bo-Bin Hu, ... Jian-Ning Jiang

Jian-Ning Jiang

Management of concomitant hepatocellular carcinoma and chronic hepatitis C: a review

Elizabeth Harrod, ... Behnam Saberi

Behnam Saberi

Advances in surface markers of liver cancer stem cell

Jin-Liang Zhang, ... Xin-Yuan Guan

Xin-Yuan Guan

Hepatocellular carcinoma: a new hope?

Lynn G. Feun

Lynn G. Feun

Hepatocellular carcinoma occurred in a Hepatitis B carrier clinic cohort during a mean follow up of 10 years

Cheng-Jen Chen, ... Dar-In Tai

Dar-In Tai

Advances in early diagnosis of hepatocellular carcinoma

Partha Pratim Bose

Partha Pratim Bose

, Urmimala Chatterjee

Third time re-irradiation of liver metastasis with robotic radiosurgery: a case series

Debnarayan Dutta

Debnarayan Dutta

, ... Raghavendra Holla

Correction: Three primary malignancies in 17 years in a man with chronic hepatitis B

Peter D. Block, ... Hie-Won Hann

Hie-Won Hann

Three primary malignancies in 17 years in a man with chronic hepatitis B

Peter D. Block, ... Hie-Won Hann

Hie-Won Hann

Contrast-enhanced ultrasound with sulphur-hexafluoride in diagnosis of early HCC in cirrhosis

Antonio Giorgio

Antonio Giorgio

, ... Valentina Giorgio

Efficacy and safety of immune checkpoint therapy in hepatocellular carcinoma: meta-analysis

Weina Tang, ... Hong-Wei Zhang

Hong-Wei Zhang

Controversies of hepatectomy and adjuvant therapy for hepatocellular carcinoma: moving forward

Jian-Hong Zhong, Bang-De Xiang

Bang-De Xiang

Efficacy and safety of stereotactic body radiation therapy combined with transarterial chemoembolization for Chinese intermediate-to advanced-stage hepatocellular carcinoma patients: a systematic review and meta-analysis

Shou-Jie Zhao, ... Yong Long

Yong Long

Hepatocellular carcinoma recurrence in HCV patients treated with direct-acting antivirals after curative treatment

Shinichiro Nakamura, ... Masatoshi Tanaka

Liver carcinogenesis: diagnostic and clinical aspects of preneoplastic nodules

Mauro Borzio

Mauro Borzio

, ... Giampiero Francica

Molecular diagnosis and therapy of hepatocellular carcinoma: achievements and challenges

Xiao-Dong Zhang

Xiao-Dong Zhang

, Man Zhao

Transarterial chemoembolization combined with radiofrequency ablation in the treatment of hepatocellular carcinomas larger than 5 cm

Yi Yang, ... Wei-Lu Zhang

Liver cancer screening in China: practices and its extended questions

Jian-Guo Chen

Jian-Guo Chen

, ... Yuan-Rong Zhu

HCC incidence and recurrence after DAAs: new insights

Necati Örmeci

Necati Örmeci

Novel insights of HBV RNA in hepatitis B virus pathogenesis and clinical application

Wen-Bin Ding, ... Fu Yang

Fu Yang

Molecular diagnosis of hepatocellular carcinoma: trends in biomarkers combination to enhance early cancer detection

Tiong Sun Chia, ... John M. Luk

John M. Luk

Telomerase reverse transcriptase promoter mutations in hepatocellular carcinogenesis

Zi-Xian Ma, ... Hong Tu

Hong Tu

Hepatocellular carcinoma in non-alcoholic fatty liver disease with and without cirrhosis

Georgia Onzi, ... Jonathan Soldera

Jonathan Soldera

Circulating tumor DNAs and non-coding RNAs as potential biomarkers for hepatocellular carcinoma diagnosis, prognosis and response to therapy

Paola Guerriero, ... Elisa Callegari

Elisa Callegari

A dimethylbromobenzene-cysteine stapled peptide dual inhibitor of the p53-MDM2/MDMX interactions

Wei Jiang, ... Wang-Xiao He

Stereotactic ablative radiotherapy for hepatocellular carcinoma

Benjamin Spieler, ... Lorraine Portelance

Lorraine Portelance

Review of therapies for intermediate and advanced stage hepatocellular carcinoma, not suitable for curative therapies: a rapidly changing landscape

Brian I. Carr

Brian I. Carr

Oncogenicity of viral hepatitis B and C in the initiation of hepatic cancer stem cells

Caecilia H. C. Sukowati

Caecilia H. C. Sukowati

, ... Claudio Tiribelli

Diagnostic imaging for hepatocellular carcinoma

Adriano de Santis

Adriano de Santis

, Giulia Gallusi

Actions for 0 selected articles

Hepatoma Research

ISSN 2454-2520 (Online) 2394-5079 (Print)

[email protected]

Navigation

Follow Us

LinkedIn
Twitter
Academia
Google Scholar

Navigation

Portico

All published articles are preserved here permanently:

https://www.portico.org/publishers/oae/

Portico

All published articles are preserved here permanently:

https://www.portico.org/publishers/oae/

[email protected]

Discover Content

Language Editing

Layout & Production

Graphical Abstracts

Video Abstracts

Conference Organizer

Strategic Collaborators

Follow OAE

© 2016-2026 OAE Publishing Inc., except certain content provided by third parties

Privacy Cookies Terms of Service

The current browser is not compatible

The following browsers are recommended for the best use experience

Chrome
Firefox
Safari

Only supports Mac
Edge